Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Indivior ( (INDV) ) has provided an announcement.
On May 4, 2026, Indivior Pharmaceuticals, Inc. announced it had entered into a $175 million accelerated share repurchase agreement with Barclays Bank PLC under its existing $400 million buyback program, signaling confidence in its long-term strategy and cash generation. The company will make an upfront payment of $175 million, expects an initial delivery of 3,717,473 shares shortly after execution, anticipates final settlement by the end of June 2026, and does not expect the transaction to affect its previously issued financial guidance, while retaining $100 million of remaining authorization for potential future repurchases via various methods subject to market conditions.
The most recent analyst rating on (INDV) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on Indivior stock, see the INDV Stock Forecast page.
Spark’s Take on INDV Stock
According to Spark, TipRanks’ AI Analyst, INDV is a Neutral.
The score is driven primarily by a strong earnings-call outlook (raised guidance, accelerating SUBLOCADE performance, and sizable expected operating cash flow) and supportive technical momentum. It is meaningfully capped by weaker financial statement quality—especially negative equity and recent negative operating/free cash flow—plus only moderate valuation support at a ~21x P/E.
To see Spark’s full report on INDV stock, click here.
More about Indivior
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company and a leader in long-acting injectable treatments for opioid use disorder, focusing on evidence-based therapies that treat OUD as a chronic but manageable brain disease. With more than 25 years in addiction medicine, the company targets patients, healthcare providers, and public health systems seeking long-term recovery solutions for OUD.
Average Trading Volume: 2,504,865
Technical Sentiment Signal: Buy
Current Market Cap: $4.59B
Find detailed analytics on INDV stock on TipRanks’ Stock Analysis page.